GTR Home > Tests > Search results - CFI[gene]

Apply filters

Showing tests for all 1586 conditions

Compare labs

Your search term can be found in tests with a total of 1586 conditions. Only 1000 conditions are displayed in this filter box. Please type the name of the condition in the search box in this filter to find the specific condition. You can use the filters below to narrow down your results.
If the name of the condition you typed is not present, please try another query or search using the All GTR tab.

  • Hide states

GTR test search results for 3426[geneid]

C Clinical test, R Research test

Showing 1 to 20 of 23 tests for 1586 conditions in 15 labs

CAtypical hemolytic uremic syndrome panel

Lab: Centogene AG - the Rare Disease Company Rostock, Mecklenburg-Vorpommern, Germany
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total targets (13)

CAtypical hemolytic uremic syndrome panel

Lab: Centogene AG - the Rare Disease Company Rostock, Mecklenburg-Vorpommern, Germany
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total targets (13)

CHemolytic uremic syndrome

Lab: Centogene AG - the Rare Disease Company Rostock, Mecklenburg-Vorpommern, Germany
Test targets
Methods
  • D Deletion/duplication analysis
  • S Mutation scanning of the entire coding region

C CFI Sequence Analysis

Test targets
Methods
  • C Sequence analysis of the entire coding region

CTruGenome Predisposition Screen

Lab: Illumina Clinical Services Laboratory Illumina San Diego, California, United States
Test targets
Methods
  • C Sequence analysis of the entire coding region
Total conditions (1541)
Total targets (1578)

CTMA Panel

Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (16)
Total targets (12)

CCFI. Complete sequencing

Lab: Instituto de Medicina Genomica Paterna, Comunidad Valenciana, Spain
Test targets
Methods
  • C Sequence analysis of the entire coding region

CCFI. Complete sequencing

Lab: Instituto de Medicina Genomica Paterna, Comunidad Valenciana, Spain
Conditions
Test targets
Methods
  • C Sequence analysis of the entire coding region

CCFI Sequencing

Test targets
Methods
  • C Sequence analysis of the entire coding region

CMacular Degeneration NGS Panel

Lab: Fulgent Clinical Diagnostics Lab Fulgent Diagnostics Temple City, California, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (64)
Total targets (20)

CAtypical Hemolytic Uremic Syndrome (aHUS) Genetic Susceptibility Panel

Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total targets (10)

CComplement factor I deficiency

Test targets
Methods
  • C Sequence analysis of the entire coding region

CAtypical Hemolytic-Uremic Syndrome Panel

Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total targets (13)

C AHUS/MPGN panel

Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total targets (13)

CCFI

Test targets
Methods
  • C Sequence analysis of the entire coding region

CAHUS/MPGN panel

Test targets
Methods
  • C Sequence analysis of the entire coding region
Total targets (8)

CTest for CFI-Related Atypical Hemolytic-Uremic Syndrome

Lab: Secugen SL Madrid, Madrid, Spain
Test targets
Methods
  • C Sequence analysis of the entire coding region

CCFI-Related Atypical Hemolytic-Uremic Syndrome

Lab: Bioscientia GmbH Center for Human Genetics Ingelheim, Rheinland-Pfalz, Germany
Test targets
Methods
  • C Sequence analysis of the entire coding region

CTest for CFI-Related Atypical Hemolytic-Uremic Syndrome

Test targets
Methods
  • C Sequence analysis of the entire coding region

Showing 1 to 20 of 23 tests for 1586 conditions in 15 labs

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.

Write to the Help Desk